Target intelligence / Profile preview

Norepinephrine transporter; Serotonin transporter (NET; SERT)

Target
NET; SERT
Molecular classification
Transporter, Neurotransmitter sodium symporter family, Solute carrier family member (SLC6A2 and SLC6A4)
01

Overview

The norepinephrine transporter is a sodium-chloride dependent membrane protein (encoded by SLC6A2), restricted to noradrenergic neurons, that clears norepinephrine from the synaptic cleft via reuptake, regulating neurotransmission, mood, and attention[1][4]. The serotonin transporter (SLC6A4) performs analogous reuptake function for serotonin[2][3]. Both are major drug targets for antidepressants (SNRIs, tricyclics) and are implicated in a range of psychiatric and neurological conditions[2][6]. Drug binding sites in these transporters overlap with substrate binding pockets, and genetic or drug-induced modifications can alter their clinical efficacy and safety profiles[2][3][4].

Other names
Norepinephrine transporterNoradrenaline transporterNETSLC6A2Serotonin transporterSERTSLC6A4
02

Mechanism of action

Inhibition of reuptake of norepinephrine and/or serotonin, increasing their extracellular concentrations in the synaptic cleft. Certain drugs selectively inhibit one or both transporters, altering neurotransmission involved in mood and pain regulation.

03

Biological functions

Neurotransmitter reuptake (norepinephrine/noradrenaline and serotonin)Regulation of synaptic monoamine levelsModulation of mood, attention, pain, and other CNS functions
04

Disease associations

Neuropsychiatric disorders (depression, anxiety disorders, ADHD, pain syndromes)Neurological disorders (potentially involved in neurodegenerative diseases)
05

Safety considerations

Common SNRI/drug class-related side effects: gastrointestinal upset, insomnia, sexual dysfunction, headache, dry mouth, dizziness, sweating, constipation, loss of appetiteRisk of serotonin syndrome (from excessive serotonin due to drug interactions)Hypertension or noradrenergic side effects (especially with NET inhibitors)
06

Interacting drugs

Serotonin–norepinephrine reuptake inhibitors (SNRIs: venlafaxine, duloxetine, desvenlafaxine, levomilnacipran)

3 more in the full profile.

07

Biomarkers

Genetic polymorphisms in SLC6A2 (NET gene) and SLC6A4 (SERT gene)Transporter density or function assessed by imaging or peripheral biomarkers (mostly in research)

Beyond the preview

Go deeper on Norepinephrine transporter; Serotonin transporter (NET; SERT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Norepinephrine transporter; Serotonin transporter (NET; SERT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call